HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

FTV

Fortive Corporation (S&P 500)

Technology — Scientific & Technical Instruments

Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.

Hold 2.7 / 5 13 analysts
$64.09
+$1.17 (+1.86%)
Target: $64.23 (0.2%)
Sign in to add FTV to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$19.54B
P/E Ratio (TTM)37.48
Forward P/E19.88
EPS (TTM)$1.71
Dividend Yield0.38%
Profit Margin12.84%
Revenue Growth7.70%
ROE6.81%
Debt/Equity58.81
Recommendation Hold 2.7
Analyst Target$64.23
Analysts13
Indexes S&P 500

Technical Indicators

RSI (14)62.8
Beta0.98
SMA 20$61.79
SMA 40$61.30
52-Week High$64.56
52-Week Low$46.34
50-Day Avg$60.75
200-Day Avg$56.62
Avg Volume$3.06M
Volume$3.47M

Performance Analysis

BULLISH

FTV shows predominantly bullish signals based on its fundamentals and technicals.

- Trading near its 52-week high ($64.56), which may indicate limited upside.
+ RSI at 62.8 shows positive momentum.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
~ Modest revenue growth of 7.7% year-over-year.
~ Wall Street consensus is "Hold" from 13 analysts.
+ Average analyst target of $64.23 implies 0.2% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 28, 2026 21:00 UTC

Back to Screener Export Report